Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development — Rare Trials Summit 2025

Commercialization

• 9/19/25

Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development

Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter

What Matters to Payers: Conversations You Should Start During Phase 2